BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32058030)

  • 1. Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study.
    Hanssen NMJ; Scheijen JLJM; Houben AJHM; van de Waarenburg M; Berendschot TTJM; Webers CAB; Reesink KD; van Greevenbroek MMJ; van der Kallen C; Schaper NC; Schram MT; Henry RMA; Stehouwer CDA; Schalkwijk CG
    Diabetes Metab; 2021 Feb; 47(1):101148. PubMed ID: 32058030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Glucose Load Plasma α-Dicarbonyl Concentrations Are Increased in Individuals With Impaired Glucose Metabolism and Type 2 Diabetes: The CODAM Study.
    Maessen DE; Hanssen NM; Scheijen JL; van der Kallen CJ; van Greevenbroek MM; Stehouwer CD; Schalkwijk CG
    Diabetes Care; 2015 May; 38(5):913-20. PubMed ID: 25710921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediabetes and Type 2 Diabetes Are Associated With Generalized Microvascular Dysfunction: The Maastricht Study.
    Sörensen BM; Houben AJ; Berendschot TT; Schouten JS; Kroon AA; van der Kallen CJ; Henry RM; Koster A; Sep SJ; Dagnelie PC; Schaper NC; Schram MT; Stehouwer CD
    Circulation; 2016 Nov; 134(18):1339-1352. PubMed ID: 27678264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study.
    Hanssen NMJ; Scheijen JLJM; Jorsal A; Parving HH; Tarnow L; Rossing P; Stehouwer CDA; Schalkwijk CG
    Diabetes; 2017 Aug; 66(8):2278-2283. PubMed ID: 28588100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study.
    Tabák AG; Brunner EJ; Lindbohm JV; Singh-Manoux A; Shipley MJ; Sattar N; Kivimäki M
    Circulation; 2022 Sep; 146(13):995-1005. PubMed ID: 36004644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher habitual intake of dietary dicarbonyls is associated with higher corresponding plasma dicarbonyl concentrations and skin autofluorescence: the Maastricht Study.
    Maasen K; Eussen SJPM; Scheijen JLJM; van der Kallen CJH; Dagnelie PC; Opperhuizen A; Stehouwer CDA; van Greevenbroek MMJ; Schalkwijk CG
    Am J Clin Nutr; 2022 Jan; 115(1):34-44. PubMed ID: 34625788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.
    Hulman A; Vistisen D; Glümer C; Bergman M; Witte DR; Færch K
    Diabetologia; 2018 Jan; 61(1):101-107. PubMed ID: 28983719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased methylglyoxal formation in plasma and tissues during a glucose tolerance test is derived from exogenous glucose.
    Zhang X; Scheijen JLJM; Stehouwer CDA; Wouters K; Schalkwijk CG
    Clin Sci (Lond); 2023 Apr; 137(8):697-706. PubMed ID: 36661051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].
    Rufino M; Barbero P; Hernández D; Torres A; Lorenzo V
    Nefrologia; 2007; 27(1):30-7. PubMed ID: 17402877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.
    Rajala U; Laakso M; Qiao Q; Keinänen-Kiukaanniemi S
    Diabetes Care; 1998 Oct; 21(10):1664-9. PubMed ID: 9773727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes.
    Hanssen NMJ; Teraa M; Scheijen JLJM; Van de Waarenburg M; Gremmels H; Stehouwer CDA; Verhaar MC; Schalkwijk CG
    Diabetes Care; 2021 Jan; 44(1):157-163. PubMed ID: 33144352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients.
    Tillmann FP; Quack I; Schenk A; Grabensee B; Rump LC; Hetzel GR
    Nephrol Dial Transplant; 2012 Aug; 27(8):3330-7. PubMed ID: 22492827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
    Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study.
    Ursini F; Russo E; D'Angelo S; Arturi F; Hribal ML; D'Antona L; Bruno C; Tripepi G; Naty S; De Sarro G; Olivieri I; Grembiale RD
    Medicine (Baltimore); 2016 Feb; 95(7):e2552. PubMed ID: 26886599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community.
    Gonzalez Izundegui D; Miller PE; Shah RV; Clish CB; Walker ME; Mitchell GF; Gerszten RE; Larson MG; Vasan RS; Nayor M
    Cardiovasc Diabetol; 2022 Oct; 21(1):213. PubMed ID: 36243866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for overt diabetes by oral glucose tolerance test: stratification by fasting blood glucose and patients' age improve practicability of guidelines in cardiological routine.
    Kempf K; Füth R; Dinh W; Bansemir L; Köhler T; Bufe A; Scheffold T; Standl E; Martin S; Lankisch M
    Int J Cardiol; 2011 Jul; 150(2):201-5. PubMed ID: 20542339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study.
    Schallmoser S; Zueger T; Kraus M; Saar-Tsechansky M; Stettler C; Feuerriegel S
    J Med Internet Res; 2023 Feb; 25():e42181. PubMed ID: 36848190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.